S. Ran

发表

Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells.

J. Minna, E. Castro-Rivera, S. Ran, 2008, Cancer research.

Lymphangiogenesis and lymphatic metastasis in breast cancer.

M. Flister, S. Ran, L. Volk, 2010, Pathophysiology : the official journal of the International Society for Pathophysiology.

In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors

Johannes Waltenberger, Philip Thorpe, Lawrence Cheung, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Anti‐VEGF‐A therapy reduces lymphatic vessel density and expression of VEGFR‐3 in an orthotopic breast tumor model

M. Flister, E. Castro-Rivera, S. Ran, 2007, International journal of cancer.

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.

D. Carbone, T. Oyama, S. Nadaf, 1998, Blood.

Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells.

D. Carbone, T. Oyama, S. Nadaf, 1998, Journal of immunology.

TLR4-Induced Inflammation Is a Key Promoter of Tumor Growth, Vascularization, and Metastasis

S. Ran, Radhika J. Patel, Nihit Bhattarai, 2019, Translational Studies on Inflammation.

CLOUDS , a protocol for deriving a molecular proton density via NMR

S. Ran, J. Waltenberger, J. W. Marks, 2002 .

Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2

Wei Zhang, L. Ramdas, W. Hittelman, 2011, BMC Cancer.

Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.

J. Minna, E. Castro-Rivera, S. Ran, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Renal cell tumors convert natural killer cells to a proangiogenic phenotype

S. Ran, A. Wilber, S. Alanee, 2020, Oncotarget.

Regulation of tumor angiogenesis by the local environment.

S. Ran, Kelly L Hall, Kelly L. Hall, 2010, Frontiers in bioscience.

Tumor infarction by targeting tissue factor to tumor vasculature.

S. Ran, P. Thorpe, 2000, Cancer journal.

Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression

Ken Saito, M. Watabe, S. Hirota, 2004, Oncogene.

Development of a mouse model for assessing fatigue during chemotherapy.

R. Trammell, S. Verhulst, S. Ran, 2011, Comparative medicine.

Inhibiting NADPH Oxidases to Target Vascular and Other Pathologies: An Update on Recent Experimental and Clinical Studies

S. Ran, David X. Zhang, N. Zinkevich, 2022, Biomolecules.

Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases.

M. Flister, S. Ran, N. Desai, 2011, Neoplasia.

Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4

S. Ran, A. Wilber, Kelly L Hall, 2017, PloS one.

E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B.

K. Fürst, B. Pützer, S. Ran, 2013, Journal of molecular cell biology.

Lymphatic Endothelial Cell Progenitors in the Tumor Microenvironment.

S. Ran, Lisa D. Volk-Draper, 2020, Advances in experimental medicine and biology.

Expression of a novel marker, Ubc9, in squamous cell carcinoma of the head and neck

Y. Mo, S. Ran, K. Robbins, 2009, Head & neck.

Myeloid-Derived Lymphatic Endothelial Cell Progenitors Significantly Contribute to Lymphatic Metastasis in Clinical Breast Cancer.

S. Ran, A. Wilber, D. DeNardo, 2019, The American journal of pathology.

Oxygenation in a human tumor xenograft: manipulation through respiratory challenge and antibody-directed infarction.

R. Mason, S. Ran, A. Constantinescu, 2003, Advances in experimental medicine and biology.

Characterization of the cell‐surface procoagulant activity of T‐lymphoblastoid cell lines

A. Goodall, S. Ran, P. Thorpe, 2004, Journal of thrombosis and haemostasis : JTH.

Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors

S. Ran, A. Wilber, 2017, Journal of leukocyte biology.

Th2 Cytokines IL-4, IL-13, and IL-10 Promote Differentiation of Pro-Lymphatic Progenitors Derived from Bone Marrow Myeloid Precursors

S. Ran, A. Wilber, Nihit Bhattarai, 2022, Stem cells and development.

lymphatic endothelial cells ex vivo and in vitro Transcriptomal comparison of human dermal

S. Thurner, K. Alitalo, P. Saharinen, 2015 .

Inﬂammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF- (cid:1) B and Prox1

D. Zawieja, K. Miyazono, M. Flister, 2010 .

Tumor oxygen dynamics: correlation of in vivo MRI with histological findings.

R. Mason, S. Ran, Dawen Zhao, 2003, Neoplasia.

Use of angiopoietin-1 expression in squamous cell carcinoma of the head and neck to predict disease-free survival.

S. Ran, K. Robbins, P. Kay, 2010 .

DW-F5: A novel formulation against malignant melanoma from Wrightia tinctoria

S. Ran, M. Murty, R. J. Anto, 2015, Scientific Reports.

Macrophage-Mediated Lymphangiogenesis: The Emerging Role of Macrophages as Lymphatic Endothelial Progenitors

S. Ran, K. Montgomery, 2012, Cancers.

Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

D. Zawieja, K. Miyazono, M. Flister, 2010, Blood.

The Role of TLR4 in Chemotherapy-Driven Metastasis.

S. Ran, 2015, Cancer research.

Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis

S. Ran, Sadasivan Chittalakkottu, R. J. Anto, 2022, Cellular and Molecular Life Sciences.

Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy.

S. Ran, A. Wilber, S. Rajput, 2012, Neoplasia.

Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer

Derek C. Radisky, Erin Miller, D. Radisky, 2014, Oncotarget.

Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy.

S. Ran, P. Thorpe, 2002, International journal of radiation oncology, biology, physics.

Increased exposure of anionic phospholipids on the surface of tumor blood vessels.

S. Ran, P. Thorpe, A. Downes, 2002, Cancer research.

New Model of Macrophage Acquisition of the Lymphatic Endothelial Phenotype

M. Flister, S. Ran, Michael J. Flister, 2012, PloS one.

Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy.

M. Flister, S. Ran, N. Desai, 2008, Neoplasia.

CXM: a new tool for mapping breast cancer risk in the tumor microenvironment.

P. LaViolette, H. Jacob, J. Lazar, 2014, Cancer research.

A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model

Wei Zhang, S. Ran, P. Thorpe, 2004, Angiogenesis.

Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy.

S. Ran, P. Thorpe, Xianming Huang, 2003, Neoplasia.

The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors.

S. Ran, M. Rosenblum, P. Thorpe, 2005, Neoplasia.

Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions.

Jasjit K. Banwait, S. Batra, C. Guda, 2018, Cancer research.

IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5+ B‐ and T‐cell trafficking to tumor‐conditioned media

G. Bhanot, S. Ganesan, S. Ran, 2015, Immunology and cell biology.

Antitumor Effects of a Monoclonal Antibody that Binds Anionic Phospholipids on the Surface of Tumor Blood Vessels in Mice

S. Ran, P. Thorpe, Xianming Huang, 2005, Clinical Cancer Research.

Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature.

S. Ran, P. Thorpe, B. Gao, 1998, Cancer research.

Inflammation induces lymphangiogenesis through up-regulation of

D. Zawieja, K. Miyazono, M. Flister, 2012 .

Characterization of Prox1 and VEGFR‐3 Expression and Lymphatic Phenotype in Normal Organs of Mice Lacking p50 Subunit of NF‐κB

M. Flister, S. Ran, L. Volk, 2011, Microcirculation.

Heritable modifiers of the tumor microenvironment influence nanoparticle uptake, distribution and response to photothermal therapy

M. Flister, S. Ran, Gayatri Sharma, 2020, Theranostics.

Molecular profile and proliferative responses of rat lymphatic endothelial cells in culture.

D. Zawieja, M. Flister, S. Ran, 2006, Lymphatic research and biology.

Tumor suppressor function of Rab25 in triple‐negative breast cancer

Krishna Rao, S. Ran, L. Volk, 2010, International journal of cancer.

WNT7A Regulates Tumor Growth and Progression in Ovarian Cancer through the WNT/β-Catenin Pathway

K. Watabe, S. Ran, K. Hayashi, 2012, Molecular Cancer Research.

Signaling and Regulation WNT 7 ARegulates Tumor Growth and Progression in Ovarian Cancer through the WNT / b-Catenin Pathway

K. Watabe, S. Ran, K. Hayashi, 2012 .

Ligand-Directed Destruction of Tumor Vasculature

S. Ran, M. Rosenblum, P. Thorpe, 2002 .

Quantitative assessment of tumor oxygen dynamics: Molecular imaging for prognostic radiology

R. Mason, S. Ran, P. Thorpe, 2002, Journal of cellular biochemistry. Supplement.

Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.

S. Ran, D. DeNardo, Sophia Ran, 2014, Cancer research.

TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer

S. Ran, S. Rajput, Lisa D. Volk-Draper, 2013, Molecular Cancer Therapeutics.

of Tumor Blood Vessels Increased Exposure of Anionic Phospholipids on the Surface Updated

S. Ran, P. Thorpe, A. Downes, 2002 .

Semaphorin 3 B ( SEMA 3 B ) induces apoptosis in lung and breast cancer , whereas VEGF 165 antagonizes this effect

J. Minna, E. Castro-Rivera, S. Ran, 2004 .

Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome

Amy R. Peck, H. Rui, Hai Hu, 2019, Breast Cancer Research and Treatment.

Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer

P. LaViolette, M. Dwinell, S. Tsaih, 2017, Breast Cancer Research and Treatment.

Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy

A. Sood, S. Ran, D. Dynda, 2019, Cancer Immunology, Immunotherapy.